SPP1 and chronic obstructive pulmonary disease: While metabolomics has indeed provided new insights into the prediction and treatment of various diseases, whether SPP1 is involved in the tryptophan metabolism pathway remains unconfirmed, necessitating further analysis in conjunction with COPD metabolomics data in the future.